Indexes end lower as Israel-Iran fighting raises investor anxiety

Published on 17/06/2025 at 22:09

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Eli Lilly and Company

Many US employers plan to pare health benefits as weight-loss spending soars	07-17	RE
Trump Reportedly Says New Pharmaceutical Tariffs Likely by July-End	07-16	MT
Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says	07-16	RE
Health Canada Expands Eli Lilly's Omvoh Indication to Crohn's, Approves Citrate-Free Formula	07-16	MT
Kailera touts late-stage win for weight-loss drug in China	07-15	RE
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	07-11	RE
FDA May Fast Track Drug Reviews for Lower US Prices	07-11	MT
FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports	07-11	MT
Guggenheim Adjusts Eli Lilly and Co.'s Price Target to $942 From $936, Keeps Buy Rating	07-11	MT
Wall Street Waits to Hear the Numbers	07-11
Eli Lilly and Co (India) with Association of Physicians of India announces launch of API - Obesity Gurukul - statement	07-11	RE
Morgan Stanley Adjusts Price Target on Eli Lilly to $1,135 From $1,133, Maintains Overweight Rating	07-10	MT
Sector Update: Health Care Stocks Higher Late Afternoon	07-09	MT
Sector Update: Health Care	07-09	MT
Öhman Health and New Technology Fund Rises 3.9% in June - Camurus Surges After Eli Lilly Partnership	07-09	FW
Eli Lilly Seen Benefiting From Higher Zepbound Sales in Q2, BofA Says	07-09	MT
Eli Lilly: new recommended dosage for Kisunla	07-09
Eli Lilly and Company Announces FDA Approves Updated Label for Lilly's Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer's Disease	07-09	CI
Eli Lilly Gets FDA Approval for Updated Kisunla Dosing for Alzheimer's	07-09	MT
Eli Lilly FDA approves updated label for Kisunla	07-09	RE
US FDA approves gradual dosing for Lilly Alzheimer's drug	07-09	RE
Trump says pharmaceutical tariffs could reach 200%	07-08	RE
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	07-08	MT
WeightWatchers names new medical chief, plans to offer menopause therapy and support	07-08	RE
Sector Update: Tech	07-07	MT